HealthdirectFree Australian health advice you can count on.

( ARTG ) KIOVIG administered intravenously is indicated for:,1. Replacement therapy indications, Primary immunodeficiency disorders (PID);, Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,2. ‍​‍‍‍​‍‍‍‍‍‍‍‍​‍Immunomodulation indications, Idiopathic thrombocytopenia purpura (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, Guillain Barré Syndrome;, Kawasaki Disease;, Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in adults., Multifocal Motor Neuropathy (MMN).,KIOVIG administered subcutaneously is indicated for:,1. Replacement therapy indications, Primary immunodeficiency disorders (PID).